Regent Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.31M Sell
20,488
-100
-0.5% -$15.3K 0.89% 29
2022
Q3
$2.76M Buy
20,588
+25
+0.1% +$3.59K 0.81% 32
2022
Q2
$3.15M Sell
20,563
-914
-4% -$140K 0.88% 29
2022
Q1
$3.48M Sell
21,477
-967
-4% -$140K 0.81% 33
2021
Q4
$3.04M Buy
22,444
+217
+1% +$25.6K 0.66% 39
2021
Q3
$2.4M Buy
22,227
+929
+4% +$106K 0.57% 42
2021
Q2
$2.4M Sell
21,298
-240
-1% -$27K 0.56% 45
2021
Q1
$2.33M Buy
21,538
+1,310
+6% +$140K 0.59% 45
2020
Q4
$2.17M Sell
20,228
-317
-2% -$30.5K 0.6% 45
2020
Q3
$1.8M Sell
20,545
-75
-0.4% -$7.06K 0.56% 48
2020
Q2
$2.02M Buy
20,620
+4,404
+27% +$388K 0.67% 38
2020
Q1
$1.24M Sell
16,216
-815
-5% -$69.4K 0.51% 52
2019
Q4
$1.51M Sell
17,031
-2,535
-13% -$210K 0.46% 58
2019
Q3
$1.48M Sell
19,566
-1,315
-6% -$90.2K 0.49% 58
2019
Q2
$1.52M Hold
20,881
0.49% 56
2019
Q1
$1.68M Sell
20,881
-760
-4% -$62.2K 0.56% 52
2018
Q4
$2M Buy
21,641
+775
+4% +$68.2K 0.75% 41
2018
Q3
$1.97M Buy
20,866
+7,515
+56% +$713K 0.62% 50
2018
Q2
$1.24M Buy
13,351
+106
+0.8% +$10.4K 0.41% 71
2018
Q1
$1.25M Buy
13,245
+100
+0.8% +$11K 0.42% 71
2017
Q4
$1.27M Buy
13,145
+187
+1% +$17.6K 0.42% 74
2017
Q3
$1.15M Sell
12,958
-400
-3% -$30.4K 0.39% 76
2017
Q2
$969K Buy
13,358
+914
+7% +$61.4K 0.34% 80
2017
Q1
$810K Sell
12,444
-679
-5% -$42.7K 0.31% 97
2016
Q4
$822K Sell
13,123
-1,000
-7% -$61K 0.42% 75
2016
Q3
$891K Hold
14,123
0.46% 64
2016
Q2
$874K Buy
14,123
+2,194
+18% +$134K 0.48% 61
2016
Q1
$681K Buy
11,929
+30
+0.3% +$1.67K 0.38% 79
2015
Q4
$705K Sell
11,899
-1,245
-9% -$71.7K 0.38% 80
2015
Q3
$716K Buy
13,144
+1,995
+18% +$130K 0.39% 76
2015
Q2
$749K Buy
11,149
+300
+3% +$19.6K 0.38% 79
2015
Q1
$635K Buy
10,849
+2,765
+34% +$167K 0.32% 89
2014
Q4
$529K Buy
8,084
+300
+4% +$18.9K 0.27% 106
2014
Q3
$450K Buy
7,784
+400
+5% +$22.2K 0.23% 114
2014
Q2
$417K Hold
7,384
0.21% 123
2014
Q1
$380K Sell
7,384
-550
-7% -$27.8K 0.2% 130
2013
Q4
$419K Sell
7,934
-1,220
-13% -$60K 0.24% 116
2013
Q3
$409K Buy
9,154
+2,144
+31% +$95K 0.27% 105
2013
Q2
$290K Buy
+7,010
New +$307K 0.22% 119

Other funds holding ABBV